Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.

Current opinion in nephrology and hypertension - 1 Nov 2013

Noris Marina, Remuzzi Giuseppe

Abstract excerpt

PURPOSE OF REVIEW: Several genetic and acquired abnormalities leading to abnormal activation of the alternative pathway of complement have been identified in patients with atypical hemolytic uremic syndrome (aHUS). The purpose of this review is to shed light on how advances in the understanding of aHUS pathogenesis have impacted on prevention and cure of aHUS recurrence after kidney transplantation. RECENT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Murine-Derived
Share to Atypical Hemolytic Uremic Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement Pathway, Alternative

Share to Hemolytic-Uremic Syndrome

Share to Immunosuppression Therapy

Share to Plasma Exchange

Share to Rituximab

Share to Secondary Prevention

Source

Identifiers

PMID: 24076560
DOI: 10.1097/MNH.0b013e328365b3fe

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.PMID 24076560Read ↗

Atypical hemolytic uremic syndrome recurrence after kidney transplantation.Semantic proximity Read ↗

Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.Semantic proximity Read ↗

Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome.Semantic proximity Read ↗

Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.Semantic proximity Read ↗

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Semantic proximity Read ↗

Transplantation in atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.Semantic proximity Read ↗

Liver transplantation for aHUS: still needed in the eculizumab era?Semantic proximity Read ↗

Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.Semantic proximity Read ↗

Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.Semantic proximity Read ↗

Improved Renal Recovery with Eculizumab Therapy among Children with High Prevalence of Mutation-Associated Atypical Hemolytic Uremic Syndrome: A Retrospective Cohort Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.